دورية أكاديمية

Systemic Polyarteritis Nodosa in the Young: A Single-Center Experience Over Thirty-Two Years.

التفاصيل البيبلوغرافية
العنوان: Systemic Polyarteritis Nodosa in the Young: A Single-Center Experience Over Thirty-Two Years.
المؤلفون: Eleftheriou, Despina, Dillon, Michael J., Tullus, Kjell, Marks, Stephen D., Pilkington, Clarissa A., Roebuck, Derek J., Klein, Nigel J., Brogan, Paul A.
المصدر: Arthritis & Rheumatism; Sep2013, Vol. 65 Issue 9, p2476-2485, 10p
مصطلحات موضوعية: IMMUNOSUPPRESSIVE agents, ACADEMIC medical centers, ANGIOGRAPHY, BIOPSY, BLOOD testing, CONFIDENCE intervals, MEDICAL records, MULTIVARIATE analysis, REGRESSION analysis, POLYARTERITIS nodosa, PROPORTIONAL hazards models, RETROSPECTIVE studies, DATA analysis software, KAPLAN-Meier estimator, SYMPTOMS, CHILDREN, DIAGNOSIS, THERAPEUTICS
مصطلحات جغرافية: UNITED Kingdom
مستخلص: Objective Polyarteritis nodosa (PAN) is a rare disease of childhood. The aims of this study were to describe the clinical features, treatment, and outcome of systemic childhood PAN and to identify predictors of relapse. Methods A single-center retrospective medical records review of children with PAN fulfilling the European League Against Rheumatism (EULAR)/Paediatric Rheumatology European Society (PRES)/Paediatric Rheumatology International Trials Organisation (PRINTO) classification criteria who were seen over a 32-year period was performed. Data on demographic and clinical features, treatments, relapses (recurrence of clinical signs/symptoms or occurrence of new symptoms after initial remission requiring escalation or resumption of immunosuppressive therapy), and deaths were recorded. A disease activity score was retrospectively assigned using the Paediatric Vasculitis Activity Score (PVAS) instrument. Cox regression analysis was used to identify significant predictors of relapse. Results Sixty-nine children with PAN were identified; 55% were male, and their median age was 8.5 years (range 0.9-15.8 years). Their clinical features at presentation were fever (87%), myalgia (83%), skin (88%), renal (19%), severe gastrointestinal (GI) (10%), and neurologic (10%) involvement. The PVAS at presentation was 9 of 63 (range 4-24). Histopathologic analysis of the skin showed necrotizing vasculitis in biopsy samples from 40 of 50 children. Results of selective visceral arteriography suggested the presence of PAN in 96% of patients. Treatment included cyclophosphamide and corticosteroids (83%), plasma exchange (9%), and biologic agents (after 2002; 13%). The relapse rate was 35%, and the mortality rate was 4%. Severe GI involvement was associated with increased risk of relapse ( P = 0.031), while longer time to induce remission ( P = 0.022) and increased cumulative dose of cyclophosphamide ( P = 0.005) were associated with lower relapse risk. Conclusion Childhood PAN is a severe inflammatory disease of insidious onset and variable clinical presentation. Relapses occurred more frequently in those with severe GI involvement. A higher cumulative dose of cyclophosphamide was associated with a lower risk of relapse. [ABSTRACT FROM AUTHOR]
Copyright of Arthritis & Rheumatism is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00043591
DOI:10.1002/art.38024